Pfizer Inks Second Collaboration with Arvinas, Makes Billion-Dollar Investment on a Novel Agent for Breast Cancer Therapy
Targeted protein degraders are increasingly becoming the most sought-after modality in drug discovery. These small molecules enable the degradation of mutated proteins through the cell’s own disposal system instead of …
Read More